Intensive chemotherapy greatly improved survival for lymphoma patientsOncology Nurse AdvisorGroupe d'Etude des Lymphomes de l'Adulte and Amgen funded the open-label randomized trial in which Groupe investigators compared two regimens: dose-inte…
ASH: Rituximab Dosing Schemes Prove Equal in Low-Burden FLMedPage TodayExplain that maintenance therapy with rituximab (Rituxan) in low-burden follicular lymphoma provided disease control that was as good as rituximab retreatment at progression. Point …
Rituximab and Liposomal Doxorubicin Improve Progression-Free and Overall …Monthly Prescribing ReferenceSAN DIEGO, CA—At the 53rd American Society of Hematology Annual Meeting and Exposition, study investigators presented evidence demonstrating prom…
R-BAC Effective In Patients With Mantle Cell Lymphoma Not Eligible for …Monthly Prescribing ReferenceSAN DIEGO, CA—The rituximab, bendamustine, and cytarabine (R-BAC) chemotherapy regimen was shown to be effective in previously untreated patients &…
Rituximab Plus Pulse Dexamethasone Effective, Tolerable in Patients with …Monthly Prescribing ReferenceSAN DIEGO, CA—Standard-dose rituximab plus multiple courses of pulse dexamethasone was shown to be active with manageable toxicity in patients wi…
Study Favors As-Needed Treatment Over Maintenance Therapy for Patients with …NEWS.GNOM.ES (press release)ES/ – Asymptomatic patients diagnosed with nonbulky follicular lymphoma, a slow-growing type of non-Hodgkin lymphoma, have traditionally been w…
Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient …PR Newswire (press release)The first clinical trial to directly compare rituximab with the new anti-CD20 monoclonal antibody obinutuzumab for the treatment of relapsed no…
Patients with Relapsed/Refractory Hodgkin's Lymphoma Benefit from VTEPA …Monthly Prescribing ReferenceOf patients with DLBCL, 70% had received prior salvage therapy with rituximab + ifosfamide, carboplatin, and etoposide (ICE) and 16% received ot…
Pixantrone Instead of Doxorubicin in CHOP-R Regimen Has Comparable Efficacy …Monthly Prescribing ReferenceSAN DIEGO, CA—For patients with untreated diffuse large B-cell lymphoma (DLBCL), CHOP-R (cyclophosphamide, doxorubicin, vincristine, prednisol…
Sarah Cannon Research Institute Presents Findings of Blood Cancer Clinical …MarketWatch (press release)… excluding Transplantation: (PI3K) Inhibitor, CAL-101 (GS-1101), in Combination with Rituximab Poster I and/or Bendamustine in Patients with Rel…